MedTrace Logo

Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement

NCT03628911 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-09-17

No results posted yet for this study

Summary

This study evaluates whether the addition of tetanizing burst therapy reduces the pain associated with ICD shocks

Conditions

  • Cardiac Electrophysiology

Interventions

DEVICE

Tetanizing Burst Therapy

Tetanizing Burst Therapy tetanizes skeletal muscle with a brief burst of stimulation prior to ICD shock, thereby reducing muscular contraction due to the shock

Sponsors & Collaborators

  • EP Sciences

    lead INDUSTRY

Principal Investigators

  • Ronald Berger, MD · Johns Hopkins University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-09-01
Completion
2020-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628911 on ClinicalTrials.gov